These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3836903)

  • 1. [In vitro activity of norfloxacin alone and in combination].
    Ferrara A; Alessandrini R; Grassi FA; Gialdroni Grassi G
    G Ital Chemioter; 1985; 32(3):531-8. PubMed ID: 3836903
    [No Abstract]   [Full Text] [Related]  

  • 2. Bactericidal and cytotoxic effect of combination of norfloxacin and 5-fluorouracil.
    Castelli M; Bertolini A; Baggio G; Aresca P; Bossa R; Galatulas I
    Anticancer Res; 1989; 9(1):49-52. PubMed ID: 2705756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro evaluation of norfloxacin on clinically isolated bacterial strains].
    Chiaradia V; Romeo AA; Pascoli L; Santini G
    Nuovi Ann Ig Microbiol; 1984; 35(6):471-81. PubMed ID: 6545701
    [No Abstract]   [Full Text] [Related]  

  • 4. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
    Martino P; Venditti M; Valente B; Brandimarte C; Serra P
    Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antibacterial activity of norfloxacin and ofloxacin in vitro by serum and experimental pleural exudates.
    Miglioli PA; Sartore P; Gianfranceschi L; Lanzafame P; Berti T
    J Chemother; 1989 Jul; 1(4 Suppl):140-1. PubMed ID: 16312342
    [No Abstract]   [Full Text] [Related]  

  • 6. Polymeric ocular drug delivery system for controlled release of norfloxacin. Part 1: In vitro characterization.
    Mukharya A; Jain SK; Dixit VK
    Pharmazie; 1994 Aug; 49(8):618-9. PubMed ID: 7938155
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activity of fluoroquinolones against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Tripathi KD; Sharma AK; Valecha N; Biswas S
    Indian J Malariol; 1993 Jun; 30(2):67-73. PubMed ID: 8405596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
    Alou L; Aguilar L; Sevillano D; Giménez MJ; Cafini F; Valero E; Relaño MT; Prieto J
    J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae.
    Chevalier J; Malléa M; Pagès JM
    Biochem J; 2000 May; 348 Pt 1(Pt 1):223-7. PubMed ID: 10794735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
    Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
    Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of subinhibitory concentrations of norfloxacin, erythromycin and roxithromycin on Pseudomonas aeruginosa virulence factors].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1995 Sep; 44(3):115-7. PubMed ID: 7489133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics sensitivity pattern of N. gonorrhoeae with special emphasis on norfloxacin and ciprofloxacin.
    Pai A; Kulkarni MG; Koppikar GV
    J Assoc Physicians India; 1999 Aug; 47(8):795-7. PubMed ID: 10778625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Actinobacillus actinomycetemcomitans strains to norfloxacin.
    Avila-Campos MJ; Mol-Resende C; Carvalho MA; Damasceno CA; Cisalpino EO
    Braz Dent J; 1995; 6(1):29-32. PubMed ID: 8688646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bismuth-norfloxacin complex: synthesis, physicochemical and antimicrobial evaluation.
    Shaikh AR; Giridhar R; Yadav MR
    Int J Pharm; 2007 Mar; 332(1-2):24-30. PubMed ID: 17174046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antimicrobial activity of ciprofloxacin and norfloxacin permanently bonded to polyethylene glycol by a thiourea linker.
    Pintér G; Horváth P; Bujdosó S; Sztaricskai F; Kéki S; Zsuga M; Kardos S; Rozgonyi F; Herczegh P
    J Antibiot (Tokyo); 2009 Feb; 62(2):113-6. PubMed ID: 19148205
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of pyochelin-norfloxacin conjugates.
    Rivault F; Liébert C; Burger A; Hoegy F; Abdallah MA; Schalk IJ; Mislin GL
    Bioorg Med Chem Lett; 2007 Feb; 17(3):640-4. PubMed ID: 17123817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid norfloxacin derivatives as prodrugs.
    Hribar-Kikelj A; Fercej-Temeljotov D; Zmitek J
    Pharmazie; 1993 Jan; 48(1):64-5. PubMed ID: 8460176
    [No Abstract]   [Full Text] [Related]  

  • 20. Postantibiotic effects of norfloxacin and netilmicin and their influence on the biological properties of Salmonella strains.
    Majtán V; Majtánová L
    Pharmazie; 1998 Jun; 53(6):410-2. PubMed ID: 9675772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.